EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access

Insights about use of p57 in differentiation between complete and partial hydatidiform mole: a scoping review

Isabelle Sasso Teixeira iD, Sheldon Rodrigo Botogoski iD, Renato Nisihara iD

Revista Brasileira de Ginecologia e Obstetrícia · 29.05.2026 · 48

DOI: 10.61622/rbgo/2026rbgo16 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Revista Brasileira de Ginecologia e Obstetrícia, erschienen am 29.05.2026. Verfasst von Isabelle Sasso Teixeira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal do Paraná Paraná Brazil Universidade Federal do Paraná, Curitiba, Paraná, Brazil. Hauptthemen laut MEDLINE: Hydatidiform Mole, Cyclin-Dependent Kinase Inhibitor p57, Uterine Neoplasms. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the utility of p57 in differentiating histological subtypes of hydatidiform mole and its applicability in clinical practice.

Methods

A scoping review was conducted following the Joanna Briggs Institute methodology and PRISMA-ScR guidelines. The article search was conducted in the PubMed, EMBASE, BVS, Cochrane, Web of Science, and Scopus databases. Studies published between 2015 and 2025 that evaluated the use of p57 in suspected cases of hydatidiform mole were included.

Results

Nine studies met the inclusion criteria. Most demonstrated high specificity of p57 for CHM diagnosis and a significant reduction in diagnostic discordance compared to morphology alone. However, p57 does not distinguish PHM from non-molar abortions. In addition, rare cases of divergent p57 expression were reported, associated with genetic alterations that may require complementary evaluation using molecular techniques.

Conclusion

IHC for p57 is a widely accessible, low-cost, and effective tool in clinical practice, particularly useful in resource-limited settings. Its routine use, in association with morphology and molecular methods when available, contributes to more accurate diagnoses and safer clinical management of GTDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydatidiform MoleCyclin-Dependent Kinase Inhibitor p57Uterine NeoplasmsHumansPregnancyFemaleDiagnosis, Differential

Stichwörter der Autor:innen

Cyclin dependent kinase inhibitor P57Gestational trophoblastic diseaseHydatidiform moleImmunohistochemistryP57 protein

Substanzen

Cyclin-Dependent Kinase Inhibitor p57CDKN1C protein, human

Autor:innen und Institutionen

  • Universidade Federal do Paraná Paraná Brazil Universidade Federal do Paraná, Curitiba, Paraná, Brazil.

ORCID-Profile: Isabelle Sasso Teixeira, Sheldon Rodrigo Botogoski, Renato Nisihara

Zitieren

APA

Teixeira, I. S., Botogoski, S. R., & Nisihara, R. (2026). Insights about use of p57 in differentiation between complete and partial hydatidiform mole: a scoping review. Revista Brasileira de Ginecologia e Obstetrícia, 48. https://doi.org/10.61622/rbgo/2026rbgo16

Vancouver

Teixeira IS, Botogoski SR, Nisihara R. Insights about use of p57 in differentiation between complete and partial hydatidiform mole: a scoping review. Revista Brasileira de Ginecologia e Obstetrícia. 2026;48. doi:10.61622/rbgo/2026rbgo16

BibTeX
@article{Teixeira2026,
  author = {Teixeira, Isabelle Sasso and Botogoski, Sheldon Rodrigo and Nisihara, Renato},
  title = {Insights about use of p57 in differentiation between complete and partial hydatidiform mole: a scoping review},
  journal = {Revista Brasileira de Ginecologia e Obstetrícia},
  year = {2026},
  volume = {48},
  doi = {10.61622/rbgo/2026rbgo16}
}
Kostenlos starten →